-
A day in the life of a scientific writer and content creator
Every career path in neuroscience can be different. Written as a Guest Blog for the British Neuroscience Association BNA, we hear from Dr. Laura Pozzi, our scientific writer, an insightful and inspiring account of her daily life at Atlas Antibodies. Read about the skills and her 3 tips for you to succeed in this job. Enjoy reading!
-
Interview with a scientist: immune resistance in lung cancer
In our new ”Interview with a Scientist” blog post, we asked Antonio Marzio, Ph.D., about his research on the mechanisms that drive immune-resistant responses in patients with non-small-cell lung carcinoma (NSCLC). Read on to learn more!
-
Research Roundup Neuroscience
Primary antibodies are a powerful tool in basic research. In our new research roundup dedicated to neuroscience, we talk about a mechanism responsible for drug resistance in epileptic patients and a newly discovered and evolutionarily conserved feature of oligodendrocytes.
-
10 ways to look at the human proteome
Antibody-based immunoassays are widely used in exploratory preclinical and pharmaceutical research as tools for discovering new druggable protein targets. Read about the 10 ways to explore and map the human proteome and how it helps researchers and clinicians on their discovery journeys.
-
2021 Recap
Twenty new blog posts, interviews with prominent scientists, employee spotlights, research highlights, acquisitions and collaborations, certification, product launches, and a new CEO. What a year for Atlas Antibodies! Read all about it.
-
Glioma classification and key molecular pathology
The classification of gliomas is changing profoundly, shifting from a morphology-based guide to a system based on molecular criteria, built around their genomic landscape and data from next-generation sequencing. Read more to learn about the key molecular markers that allow the latest classification of gliomas.
-
Research Roundup: cancer research
Our new Research Roundup summarises three cancer research studies that have used polyclonal antibodies from Atlas Antibodies. Today we share insights into a new biomarker for glioma, the metastatic process in colorectal cancer, and the effect of ginseng metabolites on cancer cells proliferation. Learn more!
-
Five questions to better understand T-cell receptors therapy
T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better.
-
Research Roundup: cell biology
Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition.
-
Research Roundup: stem cell research
Want to see our antibodies in action? Keep reading our latest Research Roundup! The following three studies have successfully utilized Atlas Antibodies products in stem cell research.
